Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editors and Section Editors for this issue.
Dr Thomas F. Patterson received his Bachelor of Arts degree from Baylor University, Waco, Texas, USA and his Medical Doctor from the University of Texas Medical School at Houston. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee, USA, and Yale-New Haven Hospital, USA, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut, USA, where he also served as an Assistant Professor of Medicine.
Dr Patterson currently is a Professor of Medicine in Infectious Diseases and Chief, Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas. He is also an Attending Physician at the South Texas Veterans Healthcare System, Audie Murphy Division, San Antonio and Director of the San Antonio Center for Medical Mycology.
He has extensive experience in opportunistic fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds.
Dr Patterson has published and lectured extensively on fungal infections. He is a member of the American Board of Internal Medicine Subspecialty on Infectious Diseases and is co-Editor-in-Chief of the popular mycology website http://www.doctorfungus.org. He is a Fellow of the American College of Physicians and Past-President of the Texas Infectious Disease Society.
Robert C. Read
Professor Robert Read trained in Medicine at the University of Sheffield, UK and completed his Doctorate Degree at Imperial College London, UK. He is Professor of Infectious Diseases and Honorary Consultant Physician in Infectious Diseases at Southampton Teaching Hospitals and the University of Southampton Medical School, UK. Professor Read trained in Infectious Disease and Internal Medicine in various posts in Leeds, Bristol, London and Nottingham, at the National Heart and Lung Institute, Imperial College London, and at the Division of Infectious Diseases, University of California, San Francisco (UCSF) at San Francisco General Hospital, USA, and was previously Professor of Infectious Diseases at the University of Sheffield. His research interests include the pathogenesis and prevention of rapidly lethal infections, notably meningococcal sepsis, influenza and pneumococcal disease.
Professor Read has had leadership roles in the UK National Institute of Health Research Clinical Research Network, the European Society for Clinical Microbiology and Infectious Diseases, and the Infectious Disease Society of America. He is an appointed member of expert advisory groups for the UK Medicines and Healthcare Products Regulatory Agency, the UK Department of Health and the European Medicines Agency. He is Editor-in-Chief of the Journal of Infection.
Professor Dockrell is a graduate of Trinity College Dublin, Ireland. After initial medical training in Dublin he moved to the Mayo Clinic, USA where he completed general internal medicine and infectious disease training. During this period he developed his subspecialty interests in HIV medicine and infections in immunocompromised hosts. His laboratory interests have focused on the role of macrophages in host defense and in the pathogenesis of HIV and bacterial infection. In particular his laboratory has investigated the role of cell death programs in enhancing microbial killing, with a particular focus on pneumococcal disease and other respiratory infections, and on how viruses such as HIV can manipulate these responses.
In 1998 Prof. Dockrell moved to the University of Sheffield, UK and has been supported by Wellcome Clinical Fellowships, including a Wellcome Senior Clinical Fellowship between 2005 and 2012. He has authored over 100 publications and book chapters. Prof. Dockrell acts as Academic Director for Communicable diseases at Sheffield Teaching Hospitals. He has contributed to several national treatment guidelines and serves on a number of research panels and professional bodies.
Karen Rogstad is a Consultant in HIV and Sexual Health at Sheffield Teaching Hospitals NHS foundation Trust, UK, and an Undergraduate Dean at the University of Sheffield Medical School, UK. She has a particular interest in young people with regards to HIV and HIV testing, sexual health, confidentiality and child sexual exploitation. She is a co-author of several guidelines including standards on young people, HIV testing, Standards for HIV services, Physical signs of Child Sexual Abuse and Reckless transmission of HIV. Additional interests include Medical Leadership and Quality in healthcare systems. She was a member of a Government Taskforce on Violence against women and children and is currently leading a Government funded grant to develop a screening tool for child sexual exploitation in sexual healthcare settings. She is Editor of the ABC of Sexually Transmitted Infections and module editor of e-HIV-STI, an online educational resource.
Suzanne Geerlings is an infectious disease specialist and staff member in the Academic Medical Center in Amsterdam, the Netherlands. The subject of her thesis (2000) was “Asymptomatic bacteriuria in women with diabetes mellitus”, for which she received two awards. She is currently project leader of several projects granted by the Netherlands Organisation for Health Research and Development or Aids Fonds, participating in many projects mainly concerning urinary tract infections, HIV-infection and quality of care, and member of different working groups for the development of (inter)national guidelines for the treatment of urinary tract infections or HIV.